poisar

Stocks · News reference

Covestro H1 EPS $0.34, Sales $7.823B

Jul 31, 2026, 10:03 AMBenzinga Newsdesk

Covestro (OTC:COVTY) reported quarterly earnings of $0.34 per share. The company reported $7.823 billion in sales this quarter.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

COVTY
Source
benzinga
Observed
Jul 31, 2026, 10:03 AM
Checked
Jul 31, 2026, 10:02 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jul 27, 2026, 9:30 AMSns Insider

    Blowing Agent Market Size to Reach USD 2.94 Billion by 2035 on Rising Demand for Low-GWP Insulation Solutions | SNS Insider

    The global blowing agent market is projected to grow from USD 1.79 billion in 2025 to USD 2.94 billion by 2035, driven by increasing demand for eco-friendly foam insulation, regulatory requirements to ban high-GWP compounds, and energy-efficient building construction. Chemical blowing agents dominate with 51.8% market share, while HFO technology is the fastest-growing segment. North America leads with 32.5% market share, with the U.S. market expected to reach USD 0.56 billion by 2035, while Europe is projected to reach USD 0.66 billion.

    Read original at globenewswire-inc
    HONCCARKAYDOWBASFY
  2. Jul 23, 2026, 8:30 AMHealthcare Foresights

    [Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)

    The global implantable cardiac fluorine-free resins market is valued at USD 1.52 billion in 2025 and is expected to grow to USD 4.26 billion by 2035 at a CAGR of 10.8%. Growth is driven by increasing cardiovascular disease prevalence, aging demographics, demand for biocompatible materials, and advancements in manufacturing technologies like additive manufacturing. Asia Pacific is projected to experience the fastest growth, while North America and Europe maintain steady expansion.

    Read original at globenewswire-inc
    COVTYBASFYDDMDT
  3. Jun 18, 2026, 4:55 PMZion Market Research

    [Latest] Polymeric Biomaterials Market Size Expected to Reach USD 267.25 Billion by 2034, With 15.86% CAGR; Increasing Focus on Regenerative Medicine to Propel Market Growth

    The global polymeric biomaterials market is projected to grow from USD 69.55 billion in 2024 to USD 267.25 billion by 2034 at a CAGR of 15.86%, driven by increasing focus on regenerative medicine, rising chronic disease prevalence, and healthcare sector expansion. Polylactic acid dominates the product segment with 28% market share, while orthopedics leads applications with 29% share. Asia-Pacific is the dominant region. However, limited mechanical strength and strict regulatory frameworks pose challenges to market growth.

    Read original at globenewswire-inc
    DDCEBASFYCOVTY